Will Soligenix Inc (OTC:SNGX) Break Its Resistance Level

Las Vegas, NV -- (SBWIRE) -- 01/30/2013 -- Soligenix Inc (OTC:SNGX) closed at $1.58 yesterday with a gain of 8.22 percent. Its highest traded value in last 52 weeks is $1.70 where as it traded lowest at $1.50. Investors have their fingers crossed that whether the share will be able to cross its 52 week high and create new resistance levels.

Soligenix Inc declared yesterday that Oral BDP program for the treatment of GI ARS has been titled as Fast Track by United State Food and Drug Administration. Previously, for Oral BDP Soligenix was also titled as Orphan Drug by FDA for saving life from radiation. Soligenix Inc is Biopharmaceutical company and is engaged in development of life saving drugs and vaccinations.

Fast Track is unique designation that is titled to medicines by FDA which has ability to cure from life threatening condition. The purpose of designating is to enhance the development and evaluation of the drug as they are considered as of high priority.

To find out what OTCMAGIC projects for Soligenix, Inc for both short term and long term please click here: SNGX

OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in stock picks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.